| 000 | 01773 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513111454.0 | ||
| 264 | 0 | _c19970415 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0166-6851 | ||
| 024 | 7 |
_a10.1016/s0166-6851(96)02746-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRitchie, G Y | |
| 245 | 0 | 0 |
_aIn vitro selection of halofantrine resistance in Plasmodium falciparum is not associated with increased expression of Pgh1. _h[electronic resource] |
| 260 |
_bMolecular and biochemical parasitology _cDec 1996 |
||
| 300 |
_a35-46 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP-Binding Cassette Transporters |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimalarials _xpharmacology |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 |
_aChloroquine _xmetabolism |
| 650 | 0 | 4 | _aDNA Fingerprinting |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xgenetics |
| 650 | 0 | 4 | _aGene Dosage |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 |
_aMefloquine _xpharmacology |
| 650 | 0 | 4 |
_aPhenanthrenes _xpharmacology |
| 650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
| 650 | 0 | 4 |
_aProtozoan Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aQuinine _xmetabolism |
| 650 | 0 | 4 | _aSelection, Genetic |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 700 | 1 | _aMungthin, M | |
| 700 | 1 | _aGreen, J E | |
| 700 | 1 | _aBray, P G | |
| 700 | 1 | _aHawley, S R | |
| 700 | 1 | _aWard, S A | |
| 773 | 0 |
_tMolecular and biochemical parasitology _gvol. 83 _gno. 1 _gp. 35-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0166-6851(96)02746-6 _zAvailable from publisher's website |
| 999 |
_c9001756 _d9001756 |
||